CD137 stimulation enhances cetuximab induced natural killer (NK): dendritic cell (DC) priming of anti-tumor T cell immunity in head and neck cancer patients

Lignende værker

• Cetuximab-activated natural killer (NK) and dendritic cells (DC) collaborate to trigger tumor antigen-specific T cell immunity in head and neck cancer patients
  af: Srivastava, Raghvendra M., et al.
  Udgivet: (2013)
• Natural killer (NK):dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity
  af: Lee, Steve C., et al.
  Udgivet: (2011)
• STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV(+) status in head and neck cancer
  af: Lu, Shanhong, et al.
  Udgivet: (2018)
• Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells
  af: Concha-Benavente, Fernando, et al.
  Udgivet: (2016)
• STAT1-Induced HLA class I Upregulation Enhances Immunogenicity and Clinical Response to anti-EGFR mAb Cetuximab Therapy in HNC Patients
  af: Srivastava, Raghvendra M., et al.
  Udgivet: (2015)